info@marketresearchfuture.com   ūüďě  +1 (855) 661-4441(US)   ūüďě  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Infectious Disease Treatment Market Research Report Information By Disease Type (Viral Diseases, Bacterial Diseases, Fungal Diseases, Parasitic Diseases and others), Treatment (Antibiotics, Antivirals, Antifungals, Anti-Parasitic and others), End User (Hospitals & Clinics, Ambulatory Care Centers and others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2030


ID: MRFR/Pharma/5566-HCR | 90 Pages | Author: Rahul Gotadki| June 2024

Global Infectious Disease Treatment Market Overview


The Infectious Disease Treatment Market is expected to reach USD 77.93 Billion by 2030 at 8.3% CAGR during the forecast period 2022-2030. Infectious diseases are caused due to organisms such as bacteria, viruses, fungi, or parasites. These diseases can be transmitted through insects, animals or by consuming contaminated food or water or by being exposed to the environment that is infected by these organisms.


Infectious Disease Treatment Market


Factors such as the rising prevalence of infectious diseases and increasing awareness regarding these diseases are expected to drive the market growth. According to an article published by the World Health Organization (WHO), nearly 50,000 people die suffering from infectious diseases every day.


However, stringent government regulations and low awareness regarding the treatment options in underdeveloped countries are expected to hamper the infectious disease treatment market growth.


Infectious Disease Treatment Market Segment Insights


The Infectious disease treatment market has been segmented into disease type, treatment, end-user, and region.


Infectious Disease Treatment Type Insights


Based on disease type, the market has been divided into viral diseases, bacterial diseases, fungal diseases, parasitic diseases, and others.


Infectious Disease Treatment Insights


The infectious disease treatment market, by treatment, has been segmented into antibiotics, antivirals, antifungals, anti-parasitic, and others.


Infectious Disease Treatment End User Insights


The market, by end-user, has been segmented into hospitals & clinics, ambulatory care centers, and others.


Infectious Disease Treatment Regional Insights


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The infectious disease treatment market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European market has been segmented into Western Europe and Eastern Europe. The market in Western Europe has further been classified into France, Germany, Spain, the UK, Italy, and the rest of Western Europe. 


The infectious disease treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.


The Middle East & Africa market has been segmented into the Middle East and Africa.


Infectious Disease Treatment Market Top Key Players


Some of the key players operating in the infectious disease treatment market are:



  • Hoffmann-La Roche Ltd (Switzerland)

  • Pfizer Inc. (US)

  • Janssen Global Services, LLC (US)

  • Sanofi (France)

  • GlaxoSmithKline PLC (UK)

  • Novartis AG (Switzerland)

  • Bristol-Myers Squibb Company (US)

  • Bayer AG (Germany)

  • Eli Lilly and Company (US)

  • Astellas Pharma Inc. (Japan)

  • Merck & Co., Inc. (US)

  • Aurobindo Pharma (India)

  • Dr. Reddy's Laboratories (India)

  • Cipla Inc. (India)

  • Alkem Labs (India)

  • AbbVie Inc. (US)


Regional Market Summary


Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is anticipated to dominate the infectious disease treatment market owing to the increasing patient population suffering from various types of infectious disease and the growing number of initiatives taken by the government to manage the spread of infectious diseases in the region. According to the Centers for Disease Control and Prevention, there were 54,285 new cases of Salmonella infection in 2017 in the US.


Europe is expected to hold the second-largest position in the infectious disease treatment market owing to the growing awareness and rising patient population suffering from various infectious diseases. According to the WHO, as of 2018, 14 million people in Europe are suffering from hepatitis C.


Asia-Pacific is expected to be the fastest-growing regional market owing to the high patient population suffering from bacterial infectious diseases and the rising number of initiatives taken by governments as well as private institutes to create awareness regarding infectious diseases. According to an article published by the National Center for Biotechnology Information (NCBI) in May 2018, nearly 22% of deaths of children below the age of 5 years in India are caused due to meningitis and pneumonia.


The infectious disease treatment market in the Middle East & Africa is expected to grow slowly, owing to the rising patient population suffering from various types of infectious diseases.


Infectious Disease Treatment Market Segmentation


Infectious Disease Treatment Disease Type Outlook



  • Viral Diseases

  • Bacterial Diseases

  • Fungal Diseases

  • Parasitic Diseases

  • Others


Infectious Disease Treatment Outlook



  • Antibiotics

  • Antivirals

  • Antifungals

  • Anti-Parasitic

  • Others


Infectious Disease Treatment End User Outlook



  • Hospitals and Clinics

  • Ambulatory Care Centers

  • Others


Infectious Disease Treatment Regional Outlook



  • Americas


    • North America


      • US

      • Canada


    • Latin America




  • Europe


    • Western Europe


      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe


    • Eastern Europe




  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific




  • Middle East & Africa


    • Middle East

    • Africa



Intended Audience



  • Biotechnology and Pharmaceutical Companies

  • Research Institutes

  • Hospitals and Clinics

  • Ambulatory Surgical Centers

  • Academic Institutes

  • Government Organizations

Report Attribute/Metric Details
  Market Size   USD 77.93 Billion
  CAGR   8.3%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Disease Type, Treatment, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Janssen Global Services, LLC (US), Sanofi (France), GlaxoSmithKline PLC (UK), Novartis AG (Switzerland), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Eli Lilly and Company (US), Astellas Pharma Inc. (Japan), Merck & Co., Inc. (US), Aurobindo Pharma (India), Dr. Reddy's Laboratories (India), Cipla Inc. (India), Alkem Labs (India), AbbVie Inc. (US)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers   Factors such as the rising prevalence of infectious diseases. increasing awareness regarding these diseases are expected to drive the market growth


Frequently Asked Questions (FAQ) :

Infectious disease treatment market is projected to grow at a 8.3% CAGR between 2022-2030

The Americas is expected to lead the infectious disease treatment market.

Increasing prevalence of infectious diseases and rising awareness are the key factors driving the infectious disease treatment market.

Strict government regulations may limit the infectious disease treatment market.

Different end users of the infectious disease treatment market include ambulatory care centers, hospitals and clinics, and others.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.